Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Judi Hirshfield-Bartek"'
Autor:
Laura E.G. Warren, Judi Hirshfield-Bartek, Hao Guo, Eren D. Yeh, Jennifer R. Bellon, Beth Overmoyer, Meredith M. Regan, Faina Nakhlis, Heather A. Jacene
Publikováno v:
Breast Cancer Research and Treatment. 151:225-232
Brain metastases are associated with significant morbidity. Minimal research has been conducted on the risk factors for and incidence of brain metastases in women with inflammatory breast cancer (IBC). 210 women with Stage III or IV IBC diagnosed fro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46f0130b6790ed177835f89813fb7e06
https://doi.org/10.1007/s10549-015-3381-8
https://doi.org/10.1007/s10549-015-3381-8
Autor:
Eren D. Yeh, Faina Nakhlis, Heather A. Jacene, Judi Hirshfield-Bartek, Hao Guo, Beth Overmoyer, Meredith M. Regan, Laura E.G. Warren, Jennifer R. Bellon
Publikováno v:
Annals of Surgical Oncology. 22:2483-2491
Inflammatory breast cancer (IBC) is a rare and aggressive subtype. This study analyzes the patterns of failure in patients with IBC treated at our institution. We retrospectively analyzed the records of 227 women with IBC presenting between 1997 and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5bde09a4724d95ee3868f2ec201d066
https://doi.org/10.1245/s10434-015-4469-4
https://doi.org/10.1245/s10434-015-4469-4
Autor:
Faina Nakhlis, Laura S. Dominici, Judi Hirshfield-Bartek, Mehra Golshan, Heather A. Jacene, Eren D. Yeh, Beth Overmoyer, Margaret M. Duggan, EE Mullaney, Laura E.G. Warren, Meredith M. Regan, Jennifer R. Bellon
Publikováno v:
Cancer Research. 73:P6-12
Introduction. Inflammatory breast cancer (IBC) is a rare and aggressive subtype of breast cancer treated with multimodality therapy consisting of preoperative systemic therapy (PST) followed by modified radical mastectomy (MRM) and chest wall and reg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc8505947a7fcaf1b66e04fd4f6407e7
https://doi.org/10.1158/0008-5472.sabcs13-p6-12-05
https://doi.org/10.1158/0008-5472.sabcs13-p6-12-05
Autor:
SN Weingart, Linda Cutone, S Kadish, Craig A. Bunnell, Katya Losk, Judi Hirshfield-Bartek, J Abeita, Mehra Golshan
Publikováno v:
Cancer Research. 73:P5-13
Background: We examined the timeliness of breast cancer care at our cancer center, focusing on care processes that affect the time from surgical consultation to surgery, with the goal of identifying improvement opportunities. Methods: We studied 584
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d8aac7da18d4bfe1f8d33447d406596
https://doi.org/10.1158/0008-5472.sabcs13-p5-13-15
https://doi.org/10.1158/0008-5472.sabcs13-p5-13-15
Autor:
Catherine S. Giess, Faina Nakhlis, Dianne Georgian-Smith, Robyn L. Birdwell, Heather A. Jacene, Jennifer R. Bellon, Annick D. Van den Abbeele, Eren D. Yeh, Beth Overmoyer, Judi Hirshfield-Bartek
Publikováno v:
Radiographics : a review publication of the Radiological Society of North America, Inc. 33(7)
Inflammatory breast cancer (IBC) is a rare breast cancer with a highly virulent course and low 5-year survival rate. Trimodality treatment that includes preoperative chemotherapy, mastectomy, and radiation therapy is the therapeutic mainstay and has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5010c78537d923231df2171ffc857156
https://pubmed.ncbi.nlm.nih.gov/24224593
https://pubmed.ncbi.nlm.nih.gov/24224593
Autor:
David Zurakowski, Margaret M. Lotz, Corrine Lenahan, Susan Schumer, Roopali Roy, Rochelle Scheib, Gwendolyn Louis, Carolyn C. Lamb, Judi Hirshfield-Bartek, Marsha A. Moses, Alexis Exarhopoulos, Virginia F. Borges, Ulla M. Wewer, Ankur Anand, Susan E. Pories, Sughra Raza, Nina Isakovich
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(5)
Matrix metalloproteinases (MMP) and a disintegrin and metalloprotease 12 (ADAM 12) can be detected in the urine of breast cancer patients and provide independent prediction of disease status. To evaluate the potential of urinary metalloproteinases as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b46c65026a2fd8779a71207f15bdf72
https://pubmed.ncbi.nlm.nih.gov/18483323
https://pubmed.ncbi.nlm.nih.gov/18483323
Autor:
Lidia Schapira, Judi Hirshfield-Bartek, Monica Morrow, Shoshana M. Rosenberg, Steven E. Come, S. Gelber, Susan Troyan, Ann H. Partridge, Meghan E. Meyer, Eric P. Winer, Michaela S. Tracy, Karen Sepucha
Publikováno v:
Annals of Internal Medicine. 159:373
Chinese translationRates of contralateral prophylactic mastectomy (CPM) have increased dramatically, particularly among younger women with breast cancer, but little is known about how women approach the decision to have CPM.To examine preferences, kn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74213fe37549390fe256855c875c164c
https://doi.org/10.7326/0003-4819-159-6-201309170-00003
https://doi.org/10.7326/0003-4819-159-6-201309170-00003